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 Abstract 
Caffeine is the probe drug of choice to assess the phenotype of the drug metabolizing enzyme 
CYP1A2. Typically, molar concentration ratios of paraxanthine, caffeine’s major metabolite, 
to its precursor are determined in plasma following administration of a caffeine test dose. The 
aim of this study was to develop and validate an LC-MS/MS method for the determination of 
caffeine and paraxanthine in hair. The different steps of a hair extraction procedure were 
thoroughly optimized. Following a three-step decontamination procedure, caffeine and 
paraxanthine were extracted from 20 mg of ground hair using a solution of protease type VIII 
in Tris buffer (pH 7.5). Resulting hair extracts were cleaned up on Strata-X
™
 SPE cartridges. 
All samples were analyzed on a Waters Acquity UPLC
®
 system coupled to an AB SCIEX 
API 4000™ triple quadrupole mass spectrometer. The final method was fully validated based 
on international guidelines. Linear calibration lines for caffeine and paraxanthine ranged from 
20 to 500 pg/mg. Precision (%RSD) and accuracy (%bias) were below 12 and 7 %, 
respectively. The isotopically labeled internal standards compensated for the ion suppression 
observed for both compounds. Relative matrix effects were below 15 %RSD. The recovery of 
the sample preparation procedure was high (> 85 %) and reproducible. Caffeine and 
paraxanthine were stable in hair for at least 644 days. The effect of the hair decontamination 
procedure was evaluated as well. Finally, the applicability of the developed procedure was 
demonstrated by determining caffeine and paraxanthine concentrations in hair samples of ten 
healthy volunteers. The optimized and validated method for determination of caffeine and 
paraxanthine in hair proved to be reliable and may serve to evaluate the potential of hair 
analysis for CYP1A2 phenotyping. 
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 1 Introduction 
Numerous approaches for qualitative and quantitative analysis of low molecular weight 
compounds in hair have been developed in the last decades. The majority of published 
methods deals with the determination of drugs of abuse and markers of alcohol use. Standard 
protocols are not available and several procedures to extract analytes from hair, such as 
extraction using organic solvents or aqueous buffers, digestion of the hair with NaOH or acid 
solutions and enzymatic digestion, have been combined with different separation and 
detection techniques, mainly GC- or LC- MS(/MS) [1,2]. Hair analysis is actively applied as 
an alternative matrix in different areas, such as clinical and forensic toxicology, abstinence 
monitoring for driving license regranting or child custody cases, workplace drug testing and 
doping control [3,4]. It provides some distinct advantages compared to traditional samples 
used in bioanalysis. Once drugs are trapped within the hair, they are no longer subject to 
biotransformation. Many drugs were shown to be stable in hair for prolonged periods of time, 
allowing retrospective assessment of drug use with a window of months up to years, 
depending on hair length. Furthermore, collecting hair strands represents a non-invasive 
sampling technique, eliminating the need for specialized personnel. On the other hand, hair 
analysis is characterized by certain inherent limitations, mainly in the interpretation of hair 
results. False positive results may result from external contamination of the hair [1-4]. 
Effective approaches to differentiate active ingestion from external contamination are subject 
of an ongoing debate in the hair analysis community. Certain drugs may also be lost from the 
hair due to cosmetic treatments, such as perming, bleaching or dying [5]. In many cases, hair 
concentrations cannot be correlated with plasma or serum concentrations.  
Recently, a novel application for hair analysis has been proposed in several studies, in which 
specific metabolites are quantified along with their parent drugs. The corresponding 
metabolite-to-parent drug concentration ratios are then used to assess the metabolic phenotype 
of drug metabolizing enzymes [6]. For example, it was found that nortriptyline/amitriptyline 
ratios in hair correlated with the number of functional alleles of CYP2C19 [7]. In another 
study, different acetylisoniazide/isoniazide ratios were found in hair samples from individuals 
with different arylamine N-acetyltransferase-2 (NAT-2) genotypes [8]. Metabolite-to-parent 
drug ratios can also be used to (retrospectively) detect changes in drug metabolism. This 
approach has been applied to demonstrate altered metabolism of nicotine [9], citalopram [10] 
and methadone [11] during pregnancy.  
The aim of our study was to develop and validate an LC-MS/MS-based procedure for the 
determination of caffeine and its major metabolite paraxanthine in hair. Caffeine is a 
generally accepted and widely used probe drug to determine the phenotype of the drug 
metabolizing enzyme CYP1A2. Since N3-demethylation of caffeine to paraxanthine is 
entirely controlled by CYP1A2, the paraxanthine/caffeine ratio provides an ideal phenotyping 
index for this enzyme [12,13]. Typically, paraxanthine/caffeine ratios are determined in 
plasma or serum 4-6 h following the administration of a defined caffeine test dose [14]. Given 
the generalized consumption of caffeine, intake of a test dose would no longer be required in 
the case of a phenotyping procedure involving hair analysis. Caffeine has been determined in 
hair using a variety of extraction media and analytical techniques, such as GC-MS, LC-UV, 
ion mobility MS, LC-QTOF-MS and LC-MS/MS [15-20], although only one published 
method was fully validated for caffeine [19]. To the best of our knowledge, our study is the 
first to provide an optimized and validated method for the combined determination of caffeine 
and its metabolite paraxanthine in hair. This method can be applied to evaluate the potential 
of hair analysis for CYP1A2 phenotyping purposes. The latter may be relevant in cases in 
which CYP1A2 phenotyping is desired but not possible, e.g. in postmortem cases involving 
an intoxication with a CYP1A2 substrate and a suspected role for aberrant CYP1A2 activity. 
The kinetics of incorporation of caffeine and paraxanthine in hair has not been investigated in 
a systematic way. Incorporation of compounds in hair is a complex process in which various 
factors are involved. From a physicochemical point of view, the incorporation rate of a given 
compound is mainly determined by its lipophilicity and basicity [1,3,4]. Given the slightly 
higher lipophilic and basic characteristics of caffeine compared to its demethylated metabolite 
paraxanthine, it can be expected that caffeine may be better incorporated into hair. In general, 
lipophilic compounds accumulate more in hair as they easily penetrate cell membranes 
through passive diffusion. In addition, given the lower pH of keratinocytes and melanocytes 
compared to plasma, basic compounds will be trapped in hair matrix cells. The incorporation 
of basic compounds is also favored by a higher affinity for binding to melanin. On the other 
hand, the more polar compound paraxanthine may show a better retention in hair [3]. Apart 
from these factors, many other variables, such as melanin content or cosmetic treatment of 
hair, may affect the incorporation and stability of caffeine and paraxanthine in hair. Therefore, 
it is difficult to accurately estimate the kinetics of the incorporation of both compounds in hair 
or their potential to replace similar ratios in plasma. To evaluate the latter, ratios in both 
matrices need to be compared on a large scale, which was out of the scope of this study. 
2 Materials and methods 
2.1 Chemicals and stock solutions 
Methanol, acetonitrile and methylene chloride were obtained from Biosolve (Valkenswaard, 
The Netherlands). A Synergy
®
 Water Purification System (Merck Millipore, Overijse, 
Belgium) provided ultrapure water. Analytical standards (caffeine, caffeine-
13
C3, 
paraxanthine, paraxanthine-
13
C4-
15
N3, theophylline, theobromine), proteases (proteinase K, 
protease type VIII, protease type XIV), dithiothreitol, trishydroxymethylaminomethane (Tris) 
and formic acid were purchased from Sigma-Aldrich (Diegem, Belgium). HCl (1N) was 
obtained from Merck KGaA (Darmstadt, Germany) and liquid N2 from Air Liquide (Brussels, 
Belgium). Stock solutions of caffeine and paraxanthine (1 mg/mL) and the IS (100 µg/mL) 
were prepared as described elsewhere [21].  
2.2 Optimization of the sample preparation procedure 
Hair samples from two caffeine consuming healthy volunteers obtained after regular haircuts 
were used for optimizing hair extraction conditions. To remove external contamination, hair 
(± 2 g) was washed in methylene chloride (20 mL for 2 min), followed by two washes in 
water (20 mL for 2 min). Two homogenization methods -manual grinding in a mortar using 
liquid N2 and mechanical grinding in a ball mill- were tested along with four different 
extraction solvents or conditions. The latter were methanol, an aqueous buffer (acetate buffer 
pH 5.0), digestion of the hair matrix with an aqueous NaOH solution (0.5 mol/L) and 
enzymatic digestion with protease type XIV (1.4 IU/mL) in acetate buffer (pH 8.5). As 
enzymatic digestion was selected, solutions of three different proteases (proteinase K, 
protease type VIII and type XIV), corresponding to 30.0 IU/mL, were prepared in Tris buffer 
(50 mmol/L) at pH 7.5 and 8.5. For all conditions, 1 mL of extraction medium was added to 
20 mg pulverized hair. All samples were gently shaken for 12 hours at 37 °C and 750 rpm on 
a Thermomixer
®
 comfort (Eppendorf, Hamburg, Germany). Subsequently, several enzymatic 
digestion and extraction parameters were optimized. Evaluated extraction times ranged from 
30 minutes to 12 hours and extractions at different temperatures (22, 37, 50 °C) were 
compared. Also the influence of the protease concentration (1.2, 6.0, 12.0, 24.0 IU/mL) and 
the Tris buffer concentration (25.0, 50.0, 100.0 mmol/L) was evaluated. Finally, the effect of 
the presence of different concentrations of dithiothreitol in the extraction medium was 
evaluated. To illustrate the performance of the optimized enzymatic procedure, a side-by-side 
comparison with extraction in methanol was performed. Therefore, aliquots of ground hair 
(20 mg) from a single volunteer were extracted using the enzymatic procedure and by adding 
1 mL of methanol to the ground hair samples. All samples were shaken for 1 h at 750 rpm and 
37 °C. 
Prior to LC-MS/MS analysis, hair extracts were cleaned-up using solid phase extraction 
(SPE). Four different SPE cartridges (Bond Elut Phenyl, C8, C18 and Phenomenex Strata-
X
™
) were tested using a general protocol. The cartridges were conditioned with 3 mL of 
methanol and 2 mL of water. Subsequently, 1 mL of hair extract was applied to the columns. 
For the wash step, 2 mL of a water/methanol mixture (85/15, v/v) was used. Finally, after 
drying for 2 minutes, the analytes were eluted from the cartridges with 4 × 250 µL of 
methanol. For all four cartridges, the recovery of caffeine and paraxanthine was determined 
by calculating the percent ratio of the peak areas of hair samples spiked at 100 pg/mg before 
extraction to those of samples spiked at the same concentration after extraction. Phenomenex 
Strata-X
™ 
cartridges were selected (see Results section) and the SPE protocol was further 
optimized by evaluating different wash solvents, being mixtures of water with methanol 
(85/15, v/v) or acetonitrile (90/10, v/v). Also the influence of using incremental proportions of 
methanol in the wash solvent was investigated. Finally, methanol, acetonitrile, 
methanol/acetonitrile (50/50, v/v), methanol/ HCl 1 mol/L (95/5, v/v), acetonitrile/ HCl 1 
mol/L (95/5, v/v) and methanol/ammonium aceteate 5 mmol/L (70/30, v/v) were evaluated as 
elution solvents. 
2.3 Final sample preparation procedure 
In the final procedure, a three-step decontamination procedure was used. Hair samples were 
first immersed in methylene chloride (20 mL) for 2 minutes and then twice in the same 
volume of water for 2 minutes. These large volumes of wash solvents were used to make sure 
there was a large excess of decontamination solvent, given the very important issue of 
external contamination in hair analysis. Wash solvents were removed and samples were air-
dried between the consecutive steps. Subsequently, samples were cut into small pieces (< 5 
mm) using scissors and manually ground in a mortar with liquid N2. Twenty mg of ground 
hair was weighed and 1 mL of a solution of protease type VIII (1.2 IU/mL) in Tris buffer (pH 
7.5, 50 mmol/L) was added. The latter solution contained the internal standards (IS) caffeine-
13
C3 and paraxanthine-
13
C4-
15
N3 at concentrations of 5 ng/mL. This results in signals that lie 
around the center of the calibration curve, in particular between the 150 pg/mg and 250 pg/mg 
calibrators. The samples were placed in a Thermomixer
®
 comfort at 37 °C and 750 rpm for 1 
hour  and subsequently centrifuged at 10000 x g for 10 minutes. An SPE procedure using 
Phenomenex Strata-X™ cartridges (200 mg, 3 mL) was used for clean-up of the supernatants. 
The cartridges were conditioned and equilibrated with 3 mL of methanol and 2 mL of water, 
respectively. Following application of the hair extracts, the cartridges were washed with 2 mL 
of a water/methanol mixture (65/35, v/v) and dried for 2 minutes. The analytes were eluted 
with 4 × 500 µL of a methanol/acetonitrile mixture (50/50, v/v). The resulting solutions were 
evaporated under a stream of N2 and redissolved in 150 µL of the mobile phase. 
2.4 LC-MS/MS method 
A Waters Acquity UPLC
®
 system (Waters, Milford, MA, USA) and an AB SCIEX API 
4000™ triple quadrupole mass spectrometer (AB SCIEX, Framingham, MA, USA) were used 
for all analyses. The LC-MS/MS configuration was controlled by AB SCIEX Analyst 1.5.2 
and Waters Acquity console software. Identical chromatography parameters as previously 
described for the analysis of caffeine and paraxanthine in dried blood spots, whole blood and 
plasma were used [21]. Mass spectrometer parameters were slightly adapted. The ion spray 
voltage was set at 4000 V, gas 1 at 40 psi, gas 2 at 80 psi, the curtain gas at 10 psi and CAD 
vacuum at 9 (arbitrary setting). All compounds were detected in scheduled multiple reaction 
monitoring (sMRM) mode. Precursor to product ion transitions were identical as previously 
described [21]. 
2.5 Validation 
Validation of the hair analysis procedure was based on European Medicines Agency (EMA) 
and U.S. Food and Drug Administration (FDA) guidelines for bioanalytical method validation 
[22,23]. Selectivity, carry-over, lower limit of quantification (LLOQ), linearity, precision, 
accuracy, matrix effect, stability and dilution integrity were evaluated. It should be noted that 
no blank, caffeine-free hair matrix was available. Hair samples from 4 young children (1 – 5 
years), collected at different time points, were analyzed; however, caffeine and paraxanthine 
were detected in all samples. A pool of hair matrix to prepare calibrators and quality control 
(QC) samples was obtained by combining decontaminated and ground hair samples in which 
the lowest concentrations of both compounds were measured. In every analytical run, the 
resulting hair matrix pool (with IS added to it) was analyzed in triplicate. The mean ratio of 
caffeine and paraxanthine to their respective IS, obtained from this analysis of triplicates, was 
calculated. To correct for the background caffeine and paraxanthine, these mean ratios were 
subtracted from the ratios that were obtained for all calibrators and QCs. We did not consider 
applying standard addition, since this would require two analyses per sample. For hair 
analysis in general (and certainly for a volunteer study, as is the case here), the amount of hair 
to be sampled remains limited because of esthetic issues. In this respect, sampling the double 
amount of hair does not seem appropriate. 
Given the lack of blank matrix, selectivity could not be assessed. Cross-interferences with 
caffeine or paraxanthine were evaluated by analyzing samples spiked with caffeine, 
paraxanthine, theophylline or theobromine at 500 pg/mg (n = 5). To evaluate the purity of the 
isotopically labeled IS, non-spiked and IS-spiked hair matrix pool samples were analyzed in 
every sample batch. Interferences were considered unacceptable if the increase in peak areas 
was higher than 20 % of the peak area of the LLOQ for the analytes and 5 % for the IS [22]. 
Potential carry-over was assessed by applying these criteria on non-spiked samples injected 
after the highest calibrator as well.  
Linearity was determined by constructing seven-point calibration lines (20, 40, 80, 150, 250, 
350, 500 pg/mg) for caffeine and paraxanthine on four consecutive days. An F-test at the 99 
% confidence level was performed and residuals were plotted against nominal concentrations 
to evaluate homoscedasticity of the data  [24]. Unweighted and weighted (1/x, 1/x², 1/√x, 1/y, 
1/y² and 1/√y) linear regression were applied and slopes and intercepts of the corresponding 
calibration lines were calculated. The sum% relative error (RE) was calculated and %RE was 
plotted against nominal concentrations to select the best-fitted calibration model [24]. Mean 
back-calculated concentrations of the calibrators should be within ± 15 % of the nominal 
value in order to accept the chosen model [22]. The LLOQ was defined as the lowest 
concentration of caffeine and paraxanthine which could be measured with %bias and %RSD 
below 20 %. 
On the same four consecutive days, QCs for caffeine and paraxanthine at four concentration 
levels were prepared and analyzed in duplicate to determine precision and accuracy. 
Assessment of accuracy ideally requires analysis of certified reference material (CRM); 
however, for caffeine and paraxanthine in hair, no CRM is available. Therefore, we opted to 
use spiked QCs for this purpose, as is commonly applied in hair analysis. Nominal QC 
concentrations were 20 (LLOQ), 60 (low), 200 (medium) and 400 (high) pg/mg. Intra- and 
interbatch precision (%RSD) were calculated using single factor ANOVA [25]. Accuracy 
(%bias) was calculated by dividing the difference between the obtained concentration and the 
nominal value by the nominal value and multiplying it by 100. %RSD and %bias should be 
within ± 15 % or within ± 20 % for the LLOQ [22]. 
Determination of matrix effects and recovery was based on the approach described by 
Matuszewski et al. [26]. Hair samples originating from five different individuals, including 
blonde, brown, dark and black hair, were spiked at low and high concentration levels 
(respectively 60 and 400 pg/mg) before (C) and after (B) extraction. Standard solutions of 
caffeine and paraxanthine in the injection solvent at the same concentration levels (A) were 
prepared as well. Absolute matrix effect values were obtained by calculating the percent ratio 
of peak areas of (B) to those of (A), absolute recovery values by calculating the percent ratio 
of peak areas of (C) to those of (B). The %RSD of absolute matrix effect and recovery values 
represented the relative matrix effect and recovery [26], the word “relative” referring to the 
comparison of the values for matrix effect and recovery between different sources of hair. 
Relative matrix effect should not exceed 15 % [22]. 
Long-term stability of caffeine and paraxanthine in hair was evaluated by analyzing ground 
hair samples in triplicate at time point zero and after various time points of storage (i.e. 7, 61, 
369 and 644 days) at ambient temperature protected from light. Processed sample stability 
was examined by re-injecting extracts of low and high QCs after 4 days of storage at 4 °C and 
7 days at -20 °C (n = 3). All stability samples were analyzed together with freshly prepared 
calibrators. The obtained concentrations should be within ± 15 % of the concentration at time 
point zero and the nominal concentration (for QCs). 
In order to safely dilute sample extracts when caffeine or paraxanthine concentrations above 
the ULOQ (500 pg/mg) are measured in real hair samples, dilution integrity was evaluated. 
Extracts of hair samples spiked at a concentration of 1000 pg/mg (n = 6) were diluted (1:5) 
with the injection solvent and analyzed. Using this dilution, the signals of the IS were high 
enough to still allow trustworthy integration of the corresponding peaks, as they were still 
within the linear range (20-500 pg/mg). The peak areas of the IS in the diluted samples were 
multiplied by 5. These peak areas were used to calculate the analyte/IS peak area ratios, from 
which the analyte concentrations were derived using the calibration curve. Finally, these 
concentrations were multiplied by 5 to obtain the actual concentrations. Accuracy and 
precision should be within ± 15 % [22]. 
2.6 Evaluation of the hair decontamination procedure 
To evaluate the effect of the hair decontamination procedure, proximal 3-cm segments of hair 
samples collected from 6 volunteers were decontaminated using the procedure described in 
section 2.3. All obtained wash solvents were analyzed for caffeine and paraxanthine.  
Therefore, methylene chloride washes were evaporated under a stream of N2 and redissolved 
in 150 µL of the mobile phase. An identical SPE procedure as used for clean-up of hair 
extracts was applied to the water washes. To ensure that this procedure was reliable when a 
higher volume (20 mL) was applied to the SPE cartridges, recovery was determined using 
solutions in water (20 mL, n = 3) in which absolute amounts of caffeine and paraxanthine 
corresponded to those present in extracts of hair samples spiked at the LLOQ concentration 
level.    
2.7 Application 
As a proof of concept, samples were collected from 10 healthy volunteers by cutting hair 
locks as close as possible to the scalp at the posterior vertex region. Caffeine and paraxanthine 
concentrations were determined in proximal 3-cm hair segments and corresponding 
paraxanthine/caffeine molar concentration ratios were calculated. This study was approved by 
the Ethics Committee of Ghent University Hospital (B670201111655). Written informed 
consent was obtained from all volunteers. No data on the participants’ caffeine intake was 
available. 
3 Results and discussion 
3.1 Sample preparation 
No significant differences were found between manual and mechanical grinding of hair 
(Figure 1). As the ball mill was not available for daily use, hair samples were manually 
ground in a mortar using liquid N2. Extraction in methanol and enzymatic digestion with 
protease type XIV gave comparable results for both caffeine and paraxanthine (Figure 1). We 
opted to further optimize the enzymatic procedure as the resulting aqueous extracts were 
clearer compared to methanolic extracts and did not require an evaporation or dilution step 
prior to SPE. Solutions of three different proteases in Tris buffer at pH 7.5 and 8.5 were 
compared. No significant differences were found at pH 8.5 for caffeine, while slightly higher 
responses were seen for paraxanthine using protease type XIV. However, considerably higher 
responses for both compounds were obtained by using protease type VIII at pH 7.5 (Figure 
2A). Hitherto, hair samples had been incubated for 12 hours at 37 °C. Different extraction 
times were evaluated and decreasing responses for caffeine and paraxanthine were found 
when samples were extracted for 2 up to 12 hours (Figure 2B). For caffeine, no influence of 
the extraction temperature was observed under the evaluated conditions, while slightly higher 
responses for paraxanthine were obtained at 37 °C (Figure 2C). Increasing the enzyme 
concentration or using Tris buffer solutions at different concentrations did not influence the 
extraction efficiency (Figure 2D and 2E, respectively). As dithiothreitol is able to reduce 
disulfide bonds of proteins, it is often applied to enhance enzymatic digestion [3]. In this 
study, however, adding dithiothreitol to the extraction medium had no positive effect, as 
analyte responses slightly decreased when higher dithiothreitol concentrations were used. 
Especially for paraxanthine, the highest peak areas were obtained when no dithiothreitol was 
present during extraction (Figure 2F). In general, peak areas of paraxanthine were higher than 
those of caffeine in these experiments. This was partly due the fact that hair from an 
individual with relatively high CYP1A2 activity was used. In addition, LC and MS 
parameters were specifically optimized to allow a sensitive determination of paraxanthine, as 
it was expected that hair concentrations of this metabolite could be low in particular cases 
(e.g. in subjects with both low caffeine intake and reduced CYP1A2 activity). In the final 
procedure, 1 mL of a protease type VIII solution at 1.2 IU/mL in Tris buffer (50 mmol/L, pH 
7.5) was added to 20 mg ground hair and samples were shaken for 1 hour at 37 °C and 750 
rpm. To evaluate the impact of optimizing the extraction conditions, this procedure was 
compared with extraction in methanol. As mentioned below, hair extracts were cleaned-up 
using SPE. While the aqueous extracts resulting from the enzymatic procedure were directly 
applied to the cartridges, the methanol extracts were either evaporated under a stream of N2 
and redissolved in water or diluted 1:3 with water prior to SPE. The latter dilution step was 
feasible since a water/methanol mixture (65/35, v/v) is used in the SPE wash step. The results 
are shown in Supplementary Figure S1. Similar results were observed for both compounds 
when methanolic extracts were evaporated or diluted prior to SPE. The responses for caffeine 
and paraxanthine obtained after the enzymatic procedure were 30 %, respectively 43 – 47 %  
higher than the responses after extraction in methanol.  
Concerning the clean-up step using SPE, the highest recovery values for caffeine and 
paraxanthine were achieved with Phenomenex Strata-X
™ 
cartridges (Table 1). Therefore, an 
optimized SPE protocol was developed for these columns. The highest response for caffeine 
was obtained using water/acetonitrile (90/10, v/v) as SPE wash solvent, while water/methanol 
(85/15, v/v) gave the best results for paraxanthine (Figure 3A). The water/methanol mixture 
was selected for further optimization because hair concentrations of paraxanthine, being a 
metabolite of caffeine, were expected to be lower. The response for caffeine decreased when 
60 % of methanol in water was used in the wash step. Paraxanthine was increasingly lost from 
the cartridges when 40 % of methanol was used (Figure 3B). Finally, several elution solvents 
were tested. For paraxanthine, no differences between the evaluated solvents were found. For 
caffeine, the solvents containing acetonitrile gave the best results (Figure 3C). For the latter 
solvents, the effect of using higher elution volumes was investigated. For acetonitrile and 
methanol/acetonitrile (50/50, v/v), slightly higher responses were obtained when 4 x 500 µL 
was applied to the cartridges (Figure 3D). In the final SPE protocol, 2 mL of a water/methanol 
mixture (65/35, v/v) was used in the wash step and 4 × 500 µL of a methanol/acetonitrile 
mixture (50/50, v/v) in the elution step. 
3.2 Validation 
No unacceptable interferences or carry-over were observed under the evaluated conditions. 
Calibrator data for both caffeine and paraxanthine were heteroscedastic. Sum% RE values as 
well as graphical representations of %RE plotted against nominal concentrations for the 
unweighted linear regression and after application of the different weighting factors were 
highly comparable. Therefore, no weighting was applied. Resulting calibration and sensitivity 
data are shown in Table 2. Back-calculated concentrations of the calibrators were within 7 and 
3 % of the nominal concentrations for caffeine and paraxanthine, respectively. Therefore, the 
selected regression models met the acceptance criteria and the calibration lines were linear. 
Intra- and interbatch precision and accuracy data for caffeine and paraxanthine QCs are 
summarized in Table 3. As %RSD and %bias lay below 12 and 7 %, respectively, the 
predefined acceptance criteria were fulfilled.  
Ion suppression was observed for both compounds, as can be seen from the absolute matrix 
effect data shown in Table 4. The signal of caffeine was suppressed to a larger extent 
compared to its metabolite paraxanthine. However, when compensation by the IS was taken 
into account, matrix effects approximated 100 %, although there was a slight 
overcompensation for caffeine at the low concentration level. Compensation by the IS also 
resulted in an improvement of relative matrix effects, which for both compounds fell within 
15 % limits. As matrix effects were assessed using samples from 5 different subjects with 
varying hair color, the latter data indicate that hair color had no apparent effect on ion 
suppression, or, at least, the effect is compensated for by the labeled IS, given the lower 
values for relative matrix effects after IS compensation. In addition, the recovery of caffeine 
and paraxanthine was determined using the same 5 hair samples (Table 4). Also here, spiked 
samples were used and, therefore, it should be noted that these results reflect the recovery of 
the SPE procedure, rather than being a true measure of the actual extraction efficiency for 
caffeine and paraxanthine from human hair. Recovery was high (> 85 %) and found to be 
reproducible for both compounds, as all relative recovery values were below 15 %RSD. An 
additional experiment with repeated extraction [27,28] of non-spiked hair containing caffeine 
and paraxanthine revealed that the recovery following a single extraction was indeed high (> 
73 %, data not shown), lying close to the values observed for spiked hair samples. 
Hair samples proved to be stable at ambient temperature for at least 644 days, with measured 
concentrations being 102.61 ± 1.05 % and 102.03 ± 6.40 % of the concentrations measured at 
time point zero for caffeine and paraxanthine, respectively. Processed samples were stable 
after 4 days of storage at 4 °C (i.e. in the autosampler) and 7 days at -20°C. Stock solutions of 
the analytes and the IS were stable for at least 6 months when stored at -20 °C. Finally, the 
dilution integrity experiment showed that extracts of hair samples could be diluted 5-fold 
without affecting accuracy and precision. Following dilution, caffeine and paraxanthine 
concentrations were measured with an accuracy (%bias) of -0.99, respectively -3.45 % and 
precision (%RSD) of 1.23, respectively 1.02%. 
3.3 Hair decontamination procedure 
At the LLOQ concentration level, the recovery of the SPE procedure was 104.44 ± 5.11 % 
and 101.02 ± 5.96 % for caffeine and paraxanthine, respectively, when solutions with a 
volume of 20 mL were applied to the cartridges. Analysis of the wash solvents of 3-cm 
proximal hair segments from 6 volunteers revealed that paraxanthine was not present in any 
of the solvents, while caffeine was detected in all cases. Peak areas were determined and all 
responses for caffeine were below the LLOQ. Although strictly taken no quantitative 
conclusions can be deduced from these data, we compared the results from the different wash 
solvents by expressing peak areas as percentage of the peak area of the LLOQ. Peak areas 
ranged from 47.7 to 79.3 % of the LLOQ (mean ± SD; 63.8 ± 11.8 %) in the methylene 
chloride wash, from 56.9 to 72.82 % (mean ± SD; 64.0 ± 5.2 %) in the first water wash and 
from 28.7 to 50.2 % (mean ± SD; 37.1 ± 7.9 %) in the second water wash. Based on these 
data, it seems that the presence of caffeine in the wash solvents is more likely to result from 
limited external contamination of the hair, rather than from premature extraction from the hair 
matrix. First, caffeine was detected in the first wash solvent consisting of methylene chloride, 
a non-protic solvent that does not make the hair swell [1,3]. Second, responses for caffeine 
overall decreased from the first to the second wash step using water, a protic solvent that 
causes swelling of the hair and may extract analytes [1,3]. Third, caffeine’s metabolite 
paraxanthine was not detected in any of the wash solvents, supporting limited external 
contamination with caffeine rather than premature extraction of the analytes. Given the 
intensity of the caffeine responses in the last wash solvents, the effect of its presence as a 
presumed contaminant on final concentrations is considered to be limited, although it may 
play a role in cases with hair concentrations near the LLOQ. 
3.4 Application 
Caffeine and paraxanthine concentrations in proximal 3-cm hair segments from 10 healthy 
volunteers (age 21 – 36 years; 7 women) are listed in Table 5, together with their 
corresponding paraxanthine/caffeine concentration ratios as potential CYP1A2 phenotyping 
metric. All measured concentrations fell into the linear concentration range of the developed 
method. A representative chromatogram of caffeine and its metabolites paraxanthine, 
theophylline and theobromine in a hair sample from one of the involved volunteers is shown 
in Figure 4. To interpret paraxanthine/caffeine ratios in hair, they need to be compared with 
reference CYP1A2 phenotyping indices. Therefore, these results served as the basis for a 
larger study in which the usefulness of paraxanthine/caffeine ratios in hair for CYP1A2 
phenotyping was evaluated by comparing hair ratios with similar ratios in the reference matrix 
plasma, following a classical CYP1A2 phenotyping protocol [29]. 
4 Conclusion 
In this study, an SPE-LC-MS/MS-based procedure for the determination of caffeine and 
paraxanthine in hair was developed and validated. By thoroughly optimizing every step of the 
extraction and clean-up procedure, a reliable and sensitive method was obtained. The final 
method was fully validated based on international guidelines and all evaluated parameters met 
the pre-established criteria. Special attention was paid to the evaluation of the effect of the 
hair decontamination procedure. Finally, the suitability of the method was demonstrated by 
applying it to hair samples of 10 healthy volunteers.  
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 Tables 
Table 1. Recovery data (n=3) for caffeine and paraxanthine spiked to hair samples at 100 
pg/mg using four different SPE cartridges. An identical SPE protocol was used for all 
cartridges. 
 Absolute recovery (mean ± SD, %) 
SPE cartridge Caffeine Paraxanthine 
Bond Elut C18 59 ± 15 5 ± 2 
Bond Elut Phenyl 83 ± 11 50 ± 7 
Bond Elut C8 103 ± 18 61 ± 1 
Phenomenex Strata-X
™
 98 ± 8 75 ± 5 
 
 
Table 2. Calibration and sensitivity data for the determination of caffeine and paraxanthine in 
hair using LC-MS/MS (n=4). 
 
Slope, 
mean  SD 
95% CI 
Intercept, 
mean  SD 
95% CI 
R
2
 
Standard 
deviation of 
residuals 
LLOQ 
(pg/mg) 
ULOQ 
(pg/mg) 
caffeine 
3.4 ± 0.3 
3.1 – 3.6 
-0.004 ± 0.008 
-0.01 – 0.004 
0.999 0.03 20 500 
paraxanthine 
4.4 ± 0.3 
4.0 – 4.7 
-0.01 ± 0.02 
-0.03 – 0.008 
1.000 0.04 20 500 
 
 
Table 3. Intra- and interbatch precision and accuracy (n=4x2) for QCs of caffeine and 
paraxanthine prepared at four concentration levels in hair. 
QC Nominal 
concentration 
(pg/mg) 
Intrabatch precision  
(%RSD) 
Interbatch precision  
(%RSD) 
Accuracy  
(%bias) 
 
caffeine 
 
paraxanthine 
 
caffeine 
 
paraxanthine 
 
caffeine 
 
paraxanthine 
LLOQ 20 6 12 12 12 6 5 
low 60 2 3 5 5 7 4 
medium 200 2 2 5 3 1 -1 
high 400 2 3 2 4 2 1 
 
 Table 4. Absolute and relative matrix effect and recovery data (n=5) for caffeine and 
paraxanthine at two concentration levels in hair samples originating from five different 
individuals. 
Caffeine 
 
Absolute matrix effect 
(mean ± SD, %) 
Relative matrix effect 
(%RSD) 
Absolute recovery 
(mean ± SD, %) 
Relative recovery 
(%RSD) 
QC 
 
without IS with IS without IS with IS without IS with IS without IS with IS 
low 66 ± 14 111 ± 13 20 12 88 ± 13 111 ± 9 15 8 
high 57 ± 7 97 ± 4 
 
13 5 89 ± 8 107 ± 7 9 6 
Paraxanthine 
 
Absolute matrix effect 
(mean ± SD, %) 
Relative matrix effect 
(%RSD) 
Absolute recovery 
(mean ± SD, %) 
Relative recovery 
(%RSD) 
QC 
 
without IS with IS without IS with IS without IS with IS without IS with IS 
low 80 ± 5 96 ± 2 6 3 96 ± 6 121 ± 7 6 6 
high 81 ± 5 100 ± 2 6 2 88 ± 4 107 ± 2 5 2 
 
 
Table 5. Caffeine and paraxanthine concentrations and corresponding paraxanthine/caffeine 
molar concentration ratios determined in proximal 3-cm hair segments of 10 healthy 
volunteers. 
Volunteer 
Caffeine 
(pg/mg) 
Paraxanthine 
(pg/mg) 
Paraxanthine/caffeine 
molar concentration ratio 
1 174 88 0.54 
2 343 95 0.30 
3 384 74 0.21 
4 366 221 0.65 
5 254 144 0.61 
6 285 33 0.13 
7 410 135 0.35 
8 205 71 0.37 
9 311 92 0.32 
10 389 269 0.75 
 
 
 
  
Figures 
Figure 1. Evaluation of different hair homogenization methods and extraction media to extract 
caffeine (A) and paraxanthine (B) from hair. Mean (n=3) peak areas of caffeine and 
paraxanthine in hair extracts are shown, with standard deviations. 
  
 
Figure 2. Optimization of enzymatic digestion and extraction parameters for the determination 
of caffeine and paraxanthine in hair. (A) Evaluation of solutions of three different proteases 
(30.0 IU/mL) in Tris buffer (50 mmol/mL, pH 7.5 and 8.5) for enzymatic digestion of hair. 
(B) Evaluation of different extraction times using 1 mL of protease type VIII (1.2 IU/mL) in 
Tris buffer (50 mmol/L, pH 7.5). (C) Evaluation of different extraction temperatures using 1 
mL of protease type VIII (1.2 IU/mL) in Tris buffer (50 mmol/L, pH 7.5). (D) Evaluation of 
different concentrations of protease type VIII in Tris buffer (50 mmol/L, pH 7.5). (E) 
Evaluation of different concentrations of Tris buffer (pH 7.5) as solvent for protease type VIII 
(1.2 IU/mL). (F) Evaluation of different concentrations of dithiothreitol added to a solution of 
protease type VIII (1.2IU/mL) in Tris buffer (50 mmol/L, pH 7.5). In all panels, mean (n=3) 
peak areas of caffeine and paraxanthine in hair extracts are shown, with standard deviations. 
 
 
  
 
Figure 3. Optimization of the wash and elution step of an SPE protocol using Phenomenex 
Strata-X
™
 cartridges. (A) Evaluation of different SPE wash solvents. (B) Evaluation of the 
addition of incremental proportions of methanol to the SPE wash solvent (water). (C) 
Evaluation of different SPE elution solvents. (D) Evaluation of different volumes of SPE 
elution solvents. In all panels, mean (n=3) peak areas of caffeine and paraxanthine in hair 
extracts are shown, with standard deviations. 
 
 
 
 
 
 
  
 
Figure 4. Chromatogram of paraxanthine, caffeine, theobromine and theophylline in a hair 
sample from a healthy volunteer. The dashed line indicates the proportion of solvent B 
(methanol containing 0.01 % formic acid) in the mobile phase over the chromatographic run. 
  
 
